Repurposing the FDA-approved raloxifene to potentiate gemcitabine cytotoxicity in pancreatic cancer

被引：0
|
作者：
Trinh, Jessica [1 ]
Badejo, Adeleke [2 ]
Love, Quintin [2 ]
True, Heather [2 ]
Rao, Deepa [2 ]
Malhotra, Ashim [2 ]
机构：
[1] Pacific Univ, Forest Grove, OR USA
[2] Pacific Univ, Sch Pharm, Hillsboro, OR USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
1212
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Structural Insights and Drug Repurposing of FDA-Approved Molecules against Human Agmatinase in Cancer Therapy
    Khan, Zeeshan
    Ikram, Saima
    Ahmad, Jamshaid
    Rehman, Irshad Ur
    Ahsan, Hina
    Ullah, Amin
    Alshaya, Dalal Sulaiman
    Fayad, Eman
    Hassan, Hesham M.
    Eldeen, Muhammad Alaa
    JOURNAL OF COMPUTATIONAL BIOPHYSICS AND CHEMISTRY, 2025,
  • [22] QUADrATiC: Scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
    O'Reilly, Paul G.
    Wen, Qing
    Bankhead, Peter
    Dunne, Philip D.
    McArt, Darragh G.
    McPherson, Suzanne
    Hamilton, Peter W.
    Mills, Ken I.
    Zhang, Shu-Dong
    BMC Bioinformatics, 2016, 17 (01):
  • [23] Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis
    Rani, Jyoti
    Silla, Yumnam
    Borah, Kasmika
    Ramachandran, Srinivasan
    Bajpai, Urmi
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (09): : 2521 - 2532
  • [24] In silico repurposing of FDA-approved drugs as multi-target inhibitors of glioblastoma
    Salaam, Ridwan Abiodun
    Afolayan, Funmilayo I. D.
    Olaniyi, Damilare Adebayo
    Oladokun, Sayo Ebenezer
    Ebuh, Rachael Pius
    Oyetunji, Ridwan Abiola
    SCIENTIFIC AFRICAN, 2025, 27
  • [25] Structure-Based Repurposing of FDA-Approved Drugs as TNF-α Inhibitors
    Leung, Chung-Hang
    Chan, Daniel Shiu-Hin
    Kwan, Maria Hiu-Tung
    Cheng, Zhen
    Wong, Chun-Yuen
    Zhu, Guo-Yuan
    Fong, Wang-Fun
    Ma, Dik-Lung
    CHEMMEDCHEM, 2011, 6 (05) : 765 - 768
  • [26] Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae
    Abutaleb, Nader S.
    Elhassanny, Ahmed E. M.
    Nocentini, Alessio
    Hewitt, Chad S.
    Elkashif, Ahmed
    Cooper, Bruce R.
    Supuran, Claudiu T.
    Seleem, Mohamed N.
    Flaherty, Daniel P.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 51 - 61
  • [27] Repurposing of FDA-approved lead drugs as potentiators of uterine contractility in postpartum hemorrhage
    Iwueke, Chisom C.
    Hansen, Christopher J.
    Siricilla, Shajila
    Herington, Jennifer L.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S325 - S325
  • [28] Repurposing the FDA-Approved Antiviral Drug Ribavirin as Targeted Therapy for Nasopharyngeal Carcinoma
    Huq, Sakibul
    Casaos, Joshua
    Serra, Riccardo
    Peters, Michael
    Xia, Yuanxuan
    Ding, Andy S.
    Ehresman, Jeff
    Kedda, Jayanidhi N.
    Morales, Manuel
    Gorelick, Noah L.
    Zhao, Tianna
    Ishida, Wataru
    Perdomo-Pantoja, Alexander
    Cecia, Arba
    Ji, Chenchen
    Suk, Ian
    Sidransky, David
    Brait, Mariana
    Brem, Henry
    Skuli, Nicolas
    Tyler, Betty
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (09) : 1797 - 1808
  • [29] QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
    Paul G. O’Reilly
    Qing Wen
    Peter Bankhead
    Philip D. Dunne
    Darragh G. McArt
    Suzanne McPherson
    Peter W. Hamilton
    Ken I. Mills
    Shu-Dong Zhang
    BMC Bioinformatics, 17
  • [30] QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics
    O'Reilly, Paul G.
    Wen, Qing
    Bankhead, Peter
    Dunne, Philip D.
    McArt, Darragh G.
    McPherson, Suzanne
    Hamilton, Peter W.
    Mills, Ken I.
    Zhang, Shu-Dong
    BMC BIOINFORMATICS, 2016, 17
12345